Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patientsDivij Mathew, Andy J. Minn, Shin Foong Ngiow et al.|Science|2024Cited by 205
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Marco Ruella, Staci Williamson et al.|NEJM Evidence|2024Cited by 20
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myelomaBeatrice M. Razzo, Alfred L. Garfall, Rajshekhar Chakraborty et al.|Blood|2025Cited by 6